Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.22B
Enterprise Value2.19B
P/E Ratio-68.4
PEG Ratio0.74
Price/Sales Ratio4.89
Price/Book Ratio1.01
Enterprise/Revenue4.77
Enterprise/EBITDA-195.44

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.09
Operating Margin-0.1
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.03

Income Statement

Revenue342.25M
Revenue/Share5.87
Gross Profit219.22M
EBITDA-19.77M
Net Income-47.02M
Diluted EPS-0.5

Balance Sheet

Total Cash287.48M
Total Cash/Share4.69
Total Debt2.53M
Total Debt/Equity0
Current Ratio8.18
Book Value Per Share18.5

Price History

52-Week Change-32.41
52-Week High38.96
52-Week Low15.7
Moving Average 50 Days19.02
Moving Average 200 Days23.11

Statistics

Average Volume1.91M
Shares Outstanding93.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.53
Payout Ratio-0.59
Last Split FactorN/A
Last Split DateN/A
AD